CTL-based Prostate Cancer Therapy

· CytoVac A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CTL-based Prostate Cancer Therapy, covering 2014-04-23 to 2014-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Repeated Dosing of a Cytotoxic Lymphocytes (CTL) Based Prostate Cancer Therapy [Phase 1]